Enhanced metabolic effect of erythropoietin and keto acids in CRF patients on low-protein diet: Czech multicenter study

American Journal of Kidney Diseases

Volumn 41, Issue 3 SUPPL. 1, 2003, Pages

  Teplan, Vladimír ^a   Schück, Otto ^b   Knotek, Antonín ^b   Hajný, Jan ^b   Horáčková, Miroslava ^b   Kvapil, Milan ^b  

^a IPVZ   (Czech Republic)

^b NONE

Author keywords

Keto acids (KAs); Low protein diet (LPD); Progression of chronic renal failure (CRF); Recombinant human erythropoietin (rHuEPO)

Indexed keywords

HIGH DENSITY LIPOPROTEIN; OXOACID; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; AMINO ACID METABOLISM; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIET SUPPLEMENTATION; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC ACTIVATION; MULTICENTER STUDY; PROSPECTIVE STUDY; PROTEIN RESTRICTION; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TISSUE OXYGENATION;

EID: 0037374176     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50079     Document Type: Conference Paper

References (14)

1. Teschan PE. Beck GE, Dwyer JT, et al: Effect of a keto acid amino acid-supplemented very low protein diet on the progression of advanced renal disease: A reanalysis of the MDRD feasibility study. Clin Nephrol 50:273-283, 1998
2. Mitch WE: Dietary therapy in uremia: The impact of nutrition on progressive renal failure. Kidney Int Suppl 75:S38-S43, 2000
3. Riedel E, Nündel M, Wendel G, Hampl H: Amino acid and a-keto acid metabolism depends on oxygen availability in chronic hemodialysis patients. Clin Nephrol 53: S56-S60, 2000(suppl 1)
4. Pollock CA, Wyndham R, Collett CV, et al: Effects of erythropoietin therapy on the lipid profile in end-stage renal failure. Kidney Int 45:897-902, 1994
5. Goto T, Saika H, Takahashi T, Maeda A, Mune M, Yukawa S: Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients. Kidney Int Suppl 71:S213-S215, 1999
6. Aparicio M. Chauvenau P, De Precigout V, Bouchet J-L, Lasseur C, Combe C: Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. J Am Soc Nephrol 11:708-716, 2000
7. Teplan V, Schück O, Horáčková M, Skibová J, Holeček M: Effect of a keto acid-amino acid supplement on the metabolism and renal elimination of branched-chain amino acids in patients with chronic renal insufficiency on a low protein diet. Wien Klin Wochenschr 112:876-881, 2000
8. Rossert J, McClellan WM, Roger SD, Vereelen DL: Epoetin treatment: What are the arguments to expect a beneficial effect on renal disease progression? Nephrol Dial Transplant 17:359-362, 2002
9. Nankivell BJ, Tay YC, Boadle RA, Harris DC: Dietary protein alters tubular iron accumulation after partial nephrectomy. Kidney Int 45:1006-1013, 1994
10. Mitch WE: Are supplements of keto acids and amino acids useful in treating patients with chronic renal failure? Wien Klin Wochenschr 112:863-864, 2000
11. Teplan V, Schück O, Kazdová L, et al: Metabolic effect of keto acid-amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin: A randomized controlled trial. Wien Klin Wochenschr 113:661-669, 2001
12. Walser M: Effects of supplemented very low protein diet in predialysis patients on the serum albumin level, proteinuria, and subsequent survival on dialysis. Miner Electrolyte Metab 24:64-71, 1998
13. Rigalleau V, Combe C, Blanchetier V, Aubertin J, Aparicio M, Gin H: Low protein diet in uremia: Effects of glucose metabolism and energy production rate. Kidney Int 51:1222-1227, 1997
14. Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag J: Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities study. Kidney Int 58:293-301, 2000